Press Office
BNMS DaTSCAN Audit Launch Print E-mail
Friday, 03 February 2012 11:34

The DaTSCAN has been used clinically throughout Europe since 2000, initially for patients with suspected Parkinson's disease (PD) and latterly for suspected Lewy body dementia (DLB).  Clinical trials have shown that the investigation is extremely useful and, to this end, NICE recommended this investigation in patients with suspected PD and suspected DLB in 2006.  In the same year, the findings from the DaTSCAN were incorporated into clinical diagnostic criteria for the diagnosis of DLB; in itself a reflection of the considerable esteem in which the findings from this study are held by the referring clinicians.
 
The British Nuclear Medicine Society (BNMS) has been in discussion with the UK neurology fraternity and British Movement Disorder Group following concerns about the lack of quality assurance for both the acquisition and reporting of these investigations.  
 

Read more... [BNMS DaTSCAN Audit Launch]
 
CardioGen-82 Radionuclide generator Print E-mail
Tuesday, 02 August 2011 15:24
The BNMS is aware of reports from the United States that there have been problems with the CardioGen-82 radionuclide generator that produces Rb-82-chloride injection for cardiac PET scanning. At this time, US Food and Drug Administration believes that the risk of harm from this exposure is minimal and it would take much more radiation to cause any severe adverse health effects in patients. The estimated amount of excess radiation that two patients have received is similar to that other patients may receive with cumulative exposure to certain other types of heart scan. This type of scan is not a commonly undertaken within the UK. The generator has been withdrawn and Rubidium-82 scanning has been suspended pending further quality control assessments.

For further information contact
Prof Alan Perkins - This e-mail address is being protected from spambots. You need JavaScript enabled to view it until 12 August
thereafter
Ms Sarah Allen - This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 
Professor Alan Perkins Awarded Honorary Fellowship of the Royal College of Physicians Print E-mail
Thursday, 28 July 2011 15:24

BNMS032In the traditional ceremony at the Royal College of Physicians in London, Professor Alan Perkins was awarded Honorary Fellowship.  This is an award made after careful consideration and scrutiny in recognition of exceptional services to the science and practice of medicine.

Professor Alan Perkins is a distinguished clinical scientist and the first non medical president of the British Nuclear Medicine Society (BNMS).  The rules of the BNMS to permit this option were amended 10 years ago but Professor Perkins was the first person who the society appointed in this role.

Professor Perkins has worked in nuclear medicine at Nottingham University for over 25 years.  He managed the Trust’s nuclear medicine and radiaton protection services for many years and worked on the team that established the new Nottingham PET-CT and Cyclotron Centre for the City Hospital campus.

His research covers fields such as tumour targeting, drug delivery and imaging gastrointestinal function.  Throughout this time he worked with the BNMS by contributing to the scientific meeting programme and developing the society’s website.

He has acted as an ambassador for Nottingham university and the BNMS by interacting with the media and responding to issues of significant impact such as the London polonium poisoning.

Initially Honorary Secretary, Professor Perkins became President of the society in 2010 and has led the society and specialty through a difficult time – for example the recent medical isotope shortages.

Notes:

The RCP was founded in 1518 by Henry VIII to license the practice of medicine ‘in the city of London and seven miles beyond’.  Today the geographical range of the RCP has extended but the mission remains the same – to set higher medical standards.

 
BNMS NMC Journal Information Print E-mail
Monday, 28 February 2011 13:03

nmcGet a free online issue - Information about NMC - Submit an Article for NMC

 
FDA issues radiation alert after CT brain perfusion overexposure Print E-mail
Thursday, 08 October 2009 00:00
The U.S. Food and Drug Administration (FDA) is investigating cases of radiation overexposure during CT brain perfusion scans conducted to aid the diagnosis and treatment of stroke. The agency said that at one particular facility, patients received radiation doses that were eight times the expected level.

By Brian Casey - This e-mail address is being protected from spambots. You need JavaScript enabled to view it
AuntMinnie.com staff writer
October 8, 2009

Read more: auntminnie.com
 
<< Start < Prev 1 2 3 4 Next > End >>

Page 1 of 4